Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review

Murji, 2017, Selective progesterone receptor modulators (SPRMs) for uterine fibroids, Cochrane Database Syst Rev Singh, 2018, The past, present and future of selective progesterone receptor modulators in the management of uterine fibroids [e-pub ahead of print], Am J Obstet Gynecol, 10.1016/j.ajog.2017.12.206 European Medicines Agency Murji, 2015, The role of ethnicity in the treatment of uterine fibroids with ulipristal acetate, J Minim Invasive Gynecol, 22, S35, 10.1016/j.jmig.2015.08.098 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med, 6, 10.1371/journal.pmed.1000100 Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 National Institute of Health European Medicines Agency Ene, 2015, Ulipristal acetate versus GnRH agonists in the treatment of uterine fibroids, BJOG, 122, 75 Niblock, 2015, Esmya-the Belfast Trust's experience, Gynecol Surg, 1, S136 Wdowiak, 2013, Pre-treatment with ulipristal acetate before ICSI procedure: a case report, Prz Menopauzalny, 17, 496 Monleon, 2014, Successful pregnancy after treatment with ulipristal acetate for uterine fibroids, Case Rep Obstet Gynecol, 2014 Romer, 2015, Case report: successful pregnancy after combined preoperative pretreatment with ulipristal acetate and laparoscopic myoma enucleation in deep-seated cervical posterior wall myoma and desire to have children, J Gynakologische Endokrinologie, 25, 32 Tikhomirov, 2015, Successful pregnancy after gigantic uterine fibroids treatment with the help of ulipristal acetate, Problemy Reproduktsii, 21, 86, 10.17116/repro201521486-88 Murad, 2016, Spontaneous pregnancy following ulipristal acetate treatment in a woman with a symptomatic uterine fibroid, J Obstet Gynaecol Can, 38, 75, 10.1016/j.jogc.2015.11.004 Luyckx, 2016, Long-term nonsurgical control with ulipristal acetate of multiple uterine fibroids, enabling pregnancy, Am J Obstet Gynecol, 214, 756, 10.1016/j.ajog.2016.02.049 Luyckx, 2014, First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids, Fertil Steril, 102, 10.1016/j.fertnstert.2014.07.1253 Wdowiak, 2014, Commentary on the article “pre-treatment with ulipristal acetate before ICSI procedure: a case report” published in Menopause Review 6/2013 (przeglad menopauzalny 2013; 6: 496–500), Prz Menopauzalny, 18, 150 Tikhomirov, 2016, Successful pregnancy following the complex treatment of gigantic uterine fibroids using ulipristal acetate. Abstract P41. International Society of Gynecologuical Endocrinology, 17th World Congress; 2016 March 2–5; Firenze, Gynecol Endocrinol, 32, 101 Donnez, 2016, Long-term medical management of uterine fibroids with ulipristal acetate, Fertil Steril, 105, 165, 10.1016/j.fertnstert.2015.09.032 Allergan Pharma Co Donnez, 2016, Uterine fibroid management: from the present to the future, Hum Reprod Update, 22, 665, 10.1093/humupd/dmw023 Willame, 2016, Myoma migration: an unexpected “effect” with ulipristal acetate treatment, Eur Rev Med Pharmacol Sci, 20, 1439 Fauser, 2017, Safety after extended repeated use of ulipristal acetate for uterine fibroids, PLoS ONE, 12, 10.1371/journal.pone.0173523 Chabbert-Buffet, 2007, Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial, J Clin Endocrinol Metab, 92, 3582, 10.1210/jc.2006-2816 Klatsky, 2008, Fibroids and reproductive outcomes: a systematic literature review from conception to delivery, Am J Obstet Gynecol, 198, 357, 10.1016/j.ajog.2007.12.039 Ciavattini, 2015, Number and size of uterine fibroids and obstetric outcomes, J Matern Fetal Neonatal Med, 28, 484, 10.3109/14767058.2014.921675 Vilos, 2015, The management of uterine leiomyomas, J Obstet Gynaecol Can, 37, 157, 10.1016/S1701-2163(15)30338-8